Every Hayes clinical evidence report is developed by experienced teams that have been trusted by healthcare decision makers since 1989. Here is a sampling of our content that is being used every day to inform defensible, evidence-based decisions by payers and providers.
Not all reports are available for public preview. For more information, please contact us.
This report addresses whether full-text clinical studies, systematic reviews, and clinical practice guidelines and position statements support the use of the Freespira biofeedback device to reduce the need for acute care, lessen panic symptom severity, and decrease the number of panic attacks in adults with panic disorder.
This report evaluates the clinical utility of the MI Profile test for the intended use as a broad molecular profiling tool.
The BlueLeaf Endovenous Valve Formation (EVF) System is an endovascular device intended to form autogenous tissue leaflets from femoral and popliteal vein walls that mimic a functional valve. It is under investigation for the treatment of deep vein reflux in chronic venous insufficiency.
Mavacamten (Camzyos) is an oral cardiac myosin inhibitor indicated for the treatment of adults with symptomatic New York Heart Association (NYHA) class II-III obstructive hypertrophic cardiomyopathy (HCM) to improve functional capacity and symptoms.
This report addresses whether full-text clinical studies, systematic reviews, and clinical practice guidelines and position statements support the use of the PillCam patency capsule (Medtronic) for verifying small bowel patency in adult patients with known or suspected strictures prior to video capsule endoscopy.
Narsoplimab is an investigational, intravenous monoclonal antibody targeting mannan-binding lectin-associated serine protease-2 (MASP-2) for the treatment of hematopoietic stem cell transplant-associated thrombotic microangiopathy (HSCT-TMA).
This report evaluates the clinical utility of the FoundationOne CDx test for the intended use as a broad molecular profiling tool.
The Agili-C is an aragonite scaffold implant indicated for the treatment of an International Cartilage Repair Society grade III or above knee-joint surface lesion(s), with a total treatable area of 1-7cm2, without severe osteoarthritis (Kellgren-Lawrence grade 0-3).
Focus of the Report: The focus of this Health Technology Assessment is the use of phrenic nerve stimulation (PNS) with the remedē System for the treatment of central sleep apnea (CSA).
Technology Description: Phrenic nerve stimulation (PNS), also known as diaphragm pacing, is the elect…
This report evaluates the analytical validity, clinical validity, and clinical utility of the PrismRA test. According to the laboratory, the PrismRA molecular signature test identifies which patients with rheumatoid arthritis (RA) are unlikely to respond to tumor necrosis factor-ɑ inhibitor (TNFi) therapies to help guide …